netupitant 300 MG / palonosetron 0.5 MG Oral Capsule [Akynzeo]

RxCUI: 1552349
RxNorm name: netupitant 300 MG / palonosetron 0.5 MG Oral Capsule [Akynzeo]
Display name: netupitant 300 MG / palonosetron 0.5 MG Oral Capsule [Akynzeo]
Full name: netupitant 300 MG / palonosetron 0.5 MG Oral Capsule [Akynzeo]
Term type: SBD
Status: DailyMed mapping
Updated: 2026-06-04 23:39:08

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
AKYNZEO	NETUPITANT AND PALONOSETRON	Helsinn Therapeutics (U.S.), Inc.	8e47618e-af46-4d82-94e8-1507c042252d	2026-06-23	Warnings, Adverse reactions	Exact identifier rxcui: 1552349

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
8e47618e-af46-4d82-94e8-1507c042252d	netupitant 300 MG / palonosetron 0.5 MG Oral Capsule [Akynzeo]	SBD	18	These highlights do not include all the information needed to use AKYNZEO® safely and effectively. See full prescribing information for AKYNZEO®. AKYNZEO® (netupitant and palonosetron) capsules, for oral use Initial U.S. Approval: 2014 AKYNZEO® (fosnetupitant and palonosetron) for injection, for intravenous use Initial U.S. Approval: 2018	20260126
8e47618e-af46-4d82-94e8-1507c042252d	Akynzeo (netupitant 300 MG / palonosetron 0.5) MG Oral Capsule	SY	18	These highlights do not include all the information needed to use AKYNZEO® safely and effectively. See full prescribing information for AKYNZEO®. AKYNZEO® (netupitant and palonosetron) capsules, for oral use Initial U.S. Approval: 2014 AKYNZEO® (fosnetupitant and palonosetron) for injection, for intravenous use Initial U.S. Approval: 2018	20260126
8e47618e-af46-4d82-94e8-1507c042252d	Akynzeo (netupitant 300 MG / palonosetron 0.5 MG (palonosetron hydrochloride 0.56 MG)) Oral Capsule	SY	18	These highlights do not include all the information needed to use AKYNZEO® safely and effectively. See full prescribing information for AKYNZEO®. AKYNZEO® (netupitant and palonosetron) capsules, for oral use Initial U.S. Approval: 2014 AKYNZEO® (fosnetupitant and palonosetron) for injection, for intravenous use Initial U.S. Approval: 2018	20260126
8e47618e-af46-4d82-94e8-1507c042252d	Akynzeo 300 MG / 0.5 MG Oral Capsule	PSN	18	These highlights do not include all the information needed to use AKYNZEO® safely and effectively. See full prescribing information for AKYNZEO®. AKYNZEO® (netupitant and palonosetron) capsules, for oral use Initial U.S. Approval: 2014 AKYNZEO® (fosnetupitant and palonosetron) for injection, for intravenous use Initial U.S. Approval: 2018	20260126